Cargando…
cGMP at the centre of attention: emerging strategies for activating the cardioprotective PKG pathway
The nitric oxide (NO)–protein kinase G (PKG) pathway has been known for some time to be an important target for cardioprotection against ischaemia/reperfusion injury and heart failure. While many approaches for reducing infarct size in patients have failed in the past, the advent of novel drugs that...
Autores principales: | Park, Min, Sandner, Peter, Krieg, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5954070/ https://www.ncbi.nlm.nih.gov/pubmed/29766323 http://dx.doi.org/10.1007/s00395-018-0679-9 |
Ejemplares similares
-
The role of cGMP and PKG in cardioprotection
por: Downey, James M, et al.
Publicado: (2009) -
Role of cGMP/PKG in fat tissue
por: Pfeifer, Alexander
Publicado: (2011) -
Structures of human PKG reveal cGMP-selectived activation mechanisms
por: Huang, Gilbert Y, et al.
Publicado: (2013) -
The Role of NO/sGC/cGMP/PKG Signaling Pathway in Regulation of Platelet Function
por: Gambaryan, Stepan
Publicado: (2022) -
PKC and AKT Modulate cGMP/PKG Signaling Pathway on Platelet Aggregation in Experimental Sepsis
por: Lopes-Pires, M. Elisa, et al.
Publicado: (2015)